Fibroz

Fibroz is Nintedanib, a multi-target tyrosine kinase inhibitor with antifibrotic activity. It is indicated for idiopathic pulmonary fibrosis, progressive fibrosing interstitial lung disease, and selected oncology settings and works by inhibiting pathways involved in fibrosis and angiogenesis.

Features